Osteoporosis Update Monica Clark Osteoporosis Nurse Description A - - PowerPoint PPT Presentation
Osteoporosis Update Monica Clark Osteoporosis Nurse Description A - - PowerPoint PPT Presentation
Osteoporosis Update Monica Clark Osteoporosis Nurse Description A reduction in bone mass with micro architectural deterioration in bone tissue leading to increase in fracture risk Fragility by loss of structure and reduced
Description
- A reduction in bone mass
- with micro architectural deterioration in bone
tissue leading to increase in fracture risk
- Fragility by loss of structure and reduced
mechanical strength.
- Fragility fractures are fractures that result
from mechanical forces that would not
- rdinarily result in fracture : a fall from
standing height.
Causes
- Ageing
- Genes/ family history / frame / inherited conditions
- Hormone status ( male + females) early menopause
- Medications: steriod use, breast / prostate cancer
treatments, Epilepsy medications
- Medical conditions. Thyroid excess, PTH excess, renal
disease
- Absorption problems; Coeliac, small bowel disease.
Anorexia, gastric surgery.
- Lifestyle, smoking, alcohol excess, reduced exercise,
longstanding poor nutrition
- Immobility, pregnancy, vitamin D deficiency
Falls and fracture care and prevention A road map for a systematic approach
Hip fracture patients
Objective 1: Improve outcomes and improve efficiency of care after hip fractures – by following the 6 “Blue Book” standards
Non-hip fragility fracture patients
Objective 2: Respond to the first fracture, prevent the second – through Fracture Liaison Services in acute and primary care
Individuals at high risk of 1st fragility fracture or other injurious falls
Objective 3: Early intervention to restore independence – through falls care pathway linking acute and urgent care services to secondary falls prevention
Older people
Objective 4: Prevent frailty, preserve bone health, reduce accidents – through preserving physical activity, healthy lifestyles and reducing environmental hazards
Stepwise implementation - based on size
- f impact
Department of Health Prevention Package for Older People: Falls and Fractures - Effective interventions in health and social care
Fragility fracture through the life span1
- 1. J Endocrinol Invest 1999;30:583-588 Kanis JA & Johnell O
- 2. Osteoporosis Review. 2009;17(1):14-16 Mitchell PJ
“Hip fracture is all too often the final destination of a 30 year journey fuelled by decreasing bone strength and increasing falls risk”2
Morbidity attributable to ageing alone Additional morbidity due to fragility fracture event
FRAX : combines risks +/_ BMD and
- ffers recommendations
- Benefits
- Web-based
- Easy to use
- 10 year projection
- Recommendation
allied with N.O.G.G
- Drawbacks
- 10 year risk
- Under estimates
treatment elderly
- Over estimates in
younger women
Current Treatments
- Anti resorption therapy: Bisphosphonates, (oral .
I.V), Denosumab (s/c)
- DABA: (Dual action bone agent) -Strontium
Ranelate , ( oral)
- Bone building therapy. Teriperatide ( s/c)
- HRT: Bone maintanence.
- Supplements, : calcium/ vitamin D, & vitamin D
Bisphosphonates
- Different degrees of
potency.
- Suppresses both
- steoblast and osteoclast
function
- Evidence of contiuned use
- n cessation of
treatment.
- Common as muck, cheap
as chips!!
- Problems
- Long term suppression
beyond therapeutic
- effect. Accrurel of
microdamage within bone
- Atypical fractures
- Osteonecrosis of the jaw
- Can cause severe
problems with gullet
Strontium Ranelate
- Unknown true
mechanism of action- some weak osteoblast stimulation
- Adds Strontium into
skeleton, big increase in BMD
- Pain to take!!
- Increased risk of cardio
vascular events
- Nausea,
- Diarrhoea in 30% of
patients.
Teriparitide
- Pulsed PTH dose
- Increases bone
formation over bone resorption
- Excellent increases in
BMD at spine and significantly reduces vertebral fracture rates in patients at very high risk.
- 2 year treatment plan.
- ( bone cancer)- need to
follow up with alternative agent
- s/c Injection every day
- Usually well tolerated
- Relatively expensive so
restrictions are quite stringent
Denosumab
- Monoclonal antibody to
- steoclast activity,
- Very specific mode of
action.
- Can be used with
patients with compromised renal function but...
- Shared care agreement
with GP’s
- 6 monthly s/c
- Swift Offset time
- Follow on therapy after
completing course
- Can drop serum calcium
and cause severe hypocalcaemia
New Treatments
- Cathepsin K: promotes osteoclast activity.
- Enzyme Cathepsin K involved in breakdown
- f collegen and allows breakdown of cartiledge and
bone
- Ondancatib is an antagonist to Cathepsin K and inhibits
bone resorption
- Reduces bone resorption and results in increases in
trabecular and corticol BMD.
- Significant reduction fractures at 3 years vertebral 54%,
non- vertebral 23% , hip 47%.
Sclerostin
- Targets osteoclasts- 90% of all bone cells..
Sclerostin has anti anabolic effect on bone formation and is bone specific.
- Target Sclerostin with antibody Romosozumab
/ Blosozumab – to have powerful effect on bone formation.
- Short lived effect and fast off set time.
- Use powerful effect, then switch to other
therapies to see continuation of improvement.
Current Issues
- Atypical femoral fractures (A.F.F.)
- Rate: 11 per 10,000 with 4-5 years use
- Rate: Hip fracture 155 per 10,000.
- Long term use of anti resorptives , Alendronic
acid , Denosumab.
- Pain pro dromal
- Spontaneous fracture
- Beaking of corticol surface. Often noted on lateral
cortex first. Localised thickening of cortex
- Often bilateral
Vertebral fracture
- Generally underestimated but significant
- fractures. 30% come to light.
- Powerful predictors of future fracture. Also allow
treatment at lower BMD.
- Often clinically silent : back pain
- Description issues at reporting ( when a fracture
is not called a fracture)
- Can be identified opportunistically. X-ray, MRI,
C.T, Barium studies.
Nutritional requirements of supplements
- National Recommendations for calcium intake
700mg per day ( equiv 1pint milk)
- Osteoporosis. Up to 1200mg. Reflected in
supplements dose
- Vitamin D: 10ug/ 400IU / day
- Safe access to sun exposure
- Foods provide up to 15% vitamin D intake, oily
fish, fortified margarines & cereals, egg yolk.
- Best advice is Healthy Plate.
Eat well plate: its all about a healthy balanced diet.
Dietary Sources of Vitamin D
Healthy advice
- Stop smoking
- Cigarettes causes early
death and imperfect functioning of bone cells
- Additional benefits
- Good for exercise
capacity
- Good for general cardio
vascular health
- Reduce alcohol use
- 3+ alcoholic drinks per
day
- Damages / reduces liver
health
- Increases Falls risk
- Risk in Elderly across